Status: Not yet recruiting
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
The purpose of this research is to determine the optimal dose, safety and tolerability of zonisamide oral suspension in children ages 1 month to 17 years of age who have partial-onset (focal) seizures. The study consists of four periods: a Screening Period (about 14 days), a Titration Period (8 weeks), a Maintenance Period (4 weeks), and a Follow-Up Period (1 week).
Participants needed: 40
Trial details
Phase: Phase 4Age: 1-17Biological sex: AllType: InterventionalSponsor: Azurity PharmaceuticalsUpdated: Jun 4, 2026Locations: 2
Eligibility criteria
Voluntarily obtained informed consent from parent/legal guardian of the particip... [+15]
Known hypersensitivity to zonisamide or to any component of the investigational... [+15]